FDA Inspection 1324204 — Direct Rx

Direct Rx — FEI 3011690045

The FDA completed an inspection of Direct Rx on Jun 4, 2026 in Dawsonville, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 4, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dawsonville, GA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.